Drug Trial Radar · NCT00002514
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
Last checked: Nov 19, 2026Latest source record: Jun 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,929
Actual
Start
May 7, 1993
Primary completion
Dec 2006
Sponsor
- Lead sponsor
- Eastern Cooperative Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI); Medical Research Council
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 15 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with allogeneic or autologous stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. It is not yet known whether stem cell transplantation is more effective than standard chemotherapy in treating acute lymphoblastic leukemia. PURPOSE: This randomized phase III trial is studying how well stem cell transplantation works compared to standard combination chemotherapy in treating patients with acute lymphoblastic leukemia in first remission.
Conditions
- Leukemia
Interventions
sargramostimBiological
asparaginaseDrug
cyclophosphamideDrug
cytarabineDrug
daunorubicin hydrochlorideDrug
dexamethasoneDrug
etoposideDrug
imatinib mesylateDrug
leucovorin calciumDrug
mercaptopurineDrug
methotrexateDrug
prednisoneDrug
thioguanineDrug
vincristine sulfateDrug
allogeneic bone marrow transplantationProcedure
autologous bone marrow transplantationProcedure
peripheral blood stem cell transplantationProcedure
radiation therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: All patients were followed for 2 years
Locations
94 sites in 1 country. Site status is shown where the registry gives one.
Aurora Presbyterian Hospital
Aurora, Colorado
Boulder Community Hospital
Boulder, Colorado
Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado
Porter Adventist Hospital
Denver, Colorado
Presbyterian - St. Luke's Medical Center
Denver, Colorado
St. Joseph Hospital
Denver, Colorado
Rose Medical Center
Denver, Colorado
CCOP - Colorado Cancer Research Program
Denver, Colorado
Swedish Medical Center
Englewood, Colorado
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
Grand Junction, Colorado
Sky Ridge Medical Center
Lone Tree, Colorado
Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado
St. Mary - Corwin Regional Medical Center
Pueblo, Colorado
North Suburban Medical Center
Thornton, Colorado
Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
Farmington, Connecticut
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut
Rush-Copley Cancer Care Center
Aurora, Illinois
Evanston Northwestern Healthcare - Evanston Hospital
Evanston, Illinois
Hinsdale Hematology Oncology Associates
Hinsdale, Illinois
Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois
Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois
CCOP - Carle Cancer Center
Urbana, Illinois
Methodist Cancer Center at Methodist Hospital
Indianapolis, Indiana
Saint Anthony Memorial Health Centers
Michigan City, Indiana
Cedar Rapids Oncology Associates
Cedar Rapids, Iowa
Siouxland Hematology-Oncology Associates, LLP
Sioux City, Iowa
Mercy Medical Center - Sioux City
Sioux City, Iowa
St. Luke's Regional Medical Center
Sioux City, Iowa
Tufts-NEMC Cancer Center
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts
Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan
CCOP - Michigan Cancer Research Consortium
Ann Arbor, Michigan
Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan
Genesys Hurley Cancer Institute
Flint, Michigan
Hurley Medical Center
Flint, Michigan
Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan
Foote Hospital
Jackson, Michigan
Borgess Medical Center
Kalamazoo, Michigan
West Michigan Cancer Center
Kalamazoo, Michigan
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.